Loading..
  • Vivesto logo
  • Vivesto logo
Vivesto
  • About Us
  • Technology & Pipeline
  • Governance
  • Investors
  • Media
  • Contact
  • About Us
    • CEO corner
    • Organisation
      • Management
      • Board of Directors
    • Partnering
    • Career
      • Vacant positions
    • Sustainability / Corporate Responsibility
  • Technology & Pipeline
    • XR-17 Technology Platform
      • Benefits
      • Therapeutic focus
      • IP protection
    • Commercialized products
      • Apealea
    • Project Pipeline
      • Cantrixil
      • Docetaxel Micellar
    • Research and development
      • XR-18
      • XR-19
    • Animal Health
  • Corporate Governance
    • Governance reports
    • General Meeting
    • Management
    • Board of Directors
    • Nomination Committee
    • Remuneration
    • Auditor
    • Code of Conduct
    • Articles of Association
    • Documents
  • Investors
    • Key value drivers
    • The Share
    • Ownership Structure
    • Financial Reports and Presentations
    • Analyst coverage
    • Prospectuses
    • Archive US listing
      • SEC Filings
      • Info regarding delisting of ADS from NASDAQ US
    • Press releases
    • Financial calendar
    • Subscribe
    • Contact
  • Media
    • Press releases
    • Presentations
    • Events
    • Subscribe
    • Image Bank
    • Contact
  • Contact

Financial calendar

2020
  • Upcoming events
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • All years
Events
    • Financial
    • All events
January 13 - January 15, 2020

Biotech Showcase™

Read more
February 13 - February 15, 2020

EORTC-PAMM 2020

Read more
June 3, 2020

Avanza’s Digitala Börsdag

Read more
September 15, 2020

Aktiedagen Digital

Read more
September 21 - September 24, 2020

Sachs Associates’ 20th Annual Biotech in Europe Forum

Read more
September 24, 2020

Erik Penser Bank’s Bolagsdag

Read more
October 7, 2020

Erik Penser Bank’s cancer research day

Read more
October 26 - October 29, 2020

BIO-Europe® 26-29 October 2020, Virtual Conference (presenting)

Read more
November 11 - November 16, 2020

Investival Showcase 11-16 November 2020, Virtual Conference (presenting)

Read more
November 17 - November 19, 2020

Jefferies London Healthcare Conference, 17-19 November 2020, Virtual (attending)

Read more
Investor contact
[email protected]
+46 18-50 54 40

Subscribe to our news

  • Investors
    • Key value drivers
    • The Share
    • Ownership Structure
    • Financial Reports and Presentations
    • Analyst coverage
    • Prospectuses
    • Archive US listing
      • SEC Filings
      • Info regarding delisting of ADS from NASDAQ US
    • Press releases
    • Financial calendar
    • Subscribe
    • Contact
Vivesto logo
  • About Us
  • Technology & Pipeline
  • Corporate Governance
  • Investors
  • Media
  • Contact

Vivesto AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Apealea® (paclitaxel micellar) is being made available to ovarian cancerpatients through a partnership with Elevar Therapeutics, Inc. Development programsinclude Cantrixil, in clinical development for late-stage ovarian cancer, and docetaxelmicellar, in development for advanced prostate cancer. Vivesto has proprietary drugdelivery technology designed to improve solubility, efficacy and safety.

The Share

Follow the share
  • Personal data
  • Cookies

OAS-MA-P-001-SEP2020

Vivesto AB
Vallongatan 1
SE-752 16 Uppsala
Tel +46 18 50 54 40
Fax +46 18 51 08 73
info@vivesto.com